Apoptosis-inducing effect of cinobufacini on human hepatoma cell line HepG 2 and its mechanism of action

Yaoxue Xuebao

Volumn 45, Issue 3, 2010, Pages 318-323

  Qi, Fang Hua ^a   Li, An Yuan ^a   Zhao, Lin ^a   Zhang, Li ^b   Du, Guan Hua ^b   Tang, Wei ^c  

^a SHANDONG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Cinobufacini; Human hepatoma cell line HepG 2; Proliferation

Indexed keywords

ANTINEOPLASTIC AGENT; CINOBUFACINI; HUACHANSU; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HEPG2; DOSE TIME EFFECT RELATION; DRUG MECHANISM; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BUFANOLIDES; CELL CYCLE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952212096     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yang LH, Jin XQ, Zhang W. Studies on the chemical constituents from the skin Bufo bufo gargarizans Cantor [J]. J Shenyang Pharm Univ, 2000, 17: 292-295.
2. Zuo XD, Cui YA, Wang JH, et al. Research on the effect of cinobufacini on human gastric neoplasm cell line MGC-80-3 [J]. Chin Clin Oncol, 2003, 8: 33-35.
3. Wang Y, Li JM, Zhang L, et al. Effect of cinobufacini on Jurkat cell line in vitro and in the animal experiment [J]. J Diagn Concept Pract, 2005, 4: 308-312.
4. -ΔΔCT method [J]. Methods, 2001, 25: 402-408. (Pubitemid 34164012)
5. Thomas M. Molecular targeted therapy for hepatocellular carcinoma [J]. J Gastroenterol, 2009, 19: 136-141.
6. The state Pharmacopoeia Committee of the People's Republic of China. Chinese Pharmacopoeia 2005 2005 [M]. Beijing: Chemical Industry Press, 2005: 265-266.
7. Qian WP. Toad'toxic and side effect on the circulatory system of experimental animals [J]. J Zhejiang Tradit Chin Med Coll, 2001, 25: 46-47.
8. Han KQ, Huang G, Gu W, et al. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice [J]. World J Gastroenterol, 2007, 13: 3374-3379. (Pubitemid 47062250)
9. Qi FH, Li AY, Gao B, et al. Apoptosis-inducing effect of Cinobufacini, Bufo bufo gargarizans Cantor skin extract, on human hepatoma cell line BEL-7402 [J]. Drug Discov Ther, 2008, 6: 339-343.
10. Takai N, Ueda T, Nishida M, et al. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells [J]. Int J Mol Med, 2008, 21: 637-643.
11. Su YH, Yin XC, Xie JM, et al. Inhibition effects of three kinds of bufotoxins on human SMMC-7721 and BEL-7402 hepatoma cell lines [J]. Acad J Sec Mil Med Univ, 2003, 24: 393-395.
12. Yip KW, Reed JC. Bcl-2 family proteins and cancer [J]. Oncogene, 2008, 27: 6398-6406.
13. Zhou YL, Hu WX, LO YP, et al. Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo [J]. Acta Pharm Sin, 2007, 42: 26-34.
14. Wang HY, Cai B, Cui CB, et al. Vitexicarpin, a flavonoid from Vitex trifolia L., induces apoptosis in K562 cells via mitochondria-controlled apoptotic pathway [J]. Acta Pharm Sin, 2005, 40: 27-31.
15. Van Delft MF, Huang DC. How the Bcl-2 family of proteins interact to regulate apoptosis [J]. Cell Res, 2006, 16: 203-213.
16. Yu Q. Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy [J]. Drug Resist Updat, 2006, 9: 19-25. (Pubitemid 43928803)
17. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis [J]. Science, 2004, 303: 1010-1014. (Pubitemid 38209704)